Breaking News

Camargo Names Chief Operating Officer

November 20, 2013

Beach brings broad experience in operations, R&D, marketing and sales

Jim Beach has been named chief operating officer for Camargo Pharmaceutical Services. Mr. Beach is a veteran healthcare executive with broad experience in operations, R&D, marketing and sales.
 
Prior to joining the company, Mr. Beach served as vice president of marketing and product management for scientific products for Cardinal Health, where he increased business unit profitability by 8%. He also served as vice president of market insights and as a member of the U.S. management board for Ethicon Endo-Surgery, as well as a leader of the global product company program for GE Healthcare. Mr. Beach is a certified GE Six Sigma quality leader and an expert at streamlining business processes.
 
“Jim’s history and accomplishments prove his business acumen and leadership skills,” said Ken Phleps, Camargo president and chief executive officer. “Camargo clients will benefit from his market research knowledge as well as his ability to build teams that can accomplish goals with speed and efficiency.”

blog comments powered by Disqus
  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Getting Real

    Michael Pollock, PPD||November 17, 2015
    Partnering for clinical and real-world evidence studies

  • Bringing Transparency and Collaboration to CRO Oversight

    Bringing Transparency and Collaboration to CRO Oversight

    Craig Morgan , goBalto Inc. ||November 17, 2015
    Relationships between sponsors and CROs are getting stronger